艾滋病毒感染者的结核病:治疗方面的进展
Vidya Mave1, Mandar Paradkar2, Francesca Conradie3
1Center for Infectious Diseases in India, Johns Hopkins India, Pune, India; School of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, USA.
The lancet. HIV
|March 27, 2025
概括
结核病的治疗时间现在更短,对于药物敏感病例的治疗方案为4个月,对于耐药结核病的治疗方案为6个月. 新的全口服治疗改善了结果,特别是对于艾滋病毒感染者来说.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 结核病 (TB) 治疗在过去的80年里发生了显著的进化,转向更短,全口服的治疗方案.
- 治疗成功率,特别是对于艾滋病毒感染者来说,往往受到免疫问题,药物水平,联合治疗挑战和社会决定因素的影响.
- 目前的指导方针建议耐药结核病治疗4-6个月,耐药结核病治疗6-9个月.
研究的目的:
- 审查结核病治疗持续时间和治疗选择方面的最新进展.
- 突出新疗法对不同人群的影响,包括艾滋病毒感染者,儿童和孕妇.
- 确定结核病消除的未来研究方向.
主要方法:
- 审查最近的临床试验和世界卫生组织 (WHO) 的建议.
- 对药物敏感和耐药结核病的新药组合和治疗持续时间的分析.
- 检查特定人群的治疗结果,包括成年人,青少年,儿童和艾滋病毒感染者.
主要成果:
- 现在建议在成人和青少年的药物敏感结核病中使用4个月的全口服治疗方案.
- 一个为期4个月的标准药物治疗方案与对药物敏感性非严重的结核病儿童的6个月治疗方案同样有效.
- 六个月的治疗方案包括贝达基林,普雷托曼尼德,莱因佐利德和莫西弗洛克萨,是耐药结核病的新标准,适用于艾滋病毒感染者和未感染者.
结论:
- 对各种形式的结核病来说,缩短治疗时间 (4-6个月) 是可行的和有效的.
- 新的全口服疗法提供了更好的结果和潜在的降低毒性,特别是在弱势群体.
- 未来的研究必须优先考虑更短,更安全,更有效的结核病治疗方法,以及创新的输送方法,以加速全球结核病消除.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...


